Lenuţa-Maria Şuta

Dr. Lenuţa-Maria Şuta

Faculty of Pharmacy, Department of Pharmaceutical Technology, “Victor Babes” University of Medicine and Pharmacy, Timisoara, ROMANIA
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Ionut LedetiIonut Ledeti
Ionut Ledeti
AAAnda Alexa
Anda Alexa
BNBercean V Vasile Nicolae
Bercean V Vasile Nicolae
GVGabriela Vlase
Gabriela Vlase
Vlase TitusVlase Titus
Vlase Titus
Adriana LedetiAdriana Ledeti
Adriana Ledeti
This paper reports on the synthesis and characterization of two Schiff bases bearing 1,2,4-triazolic moieties, namely 4H-4-(2-hydroxy-benzylidene-amino)-5-benzyl-3-mercapto-1,2,4-triazole and 4H-4-(4-nitro-benzylidene-amino)-5-benzyl-3-mercapto-1,2,4-triazole using thin layer chromatography, melting interval, elemental analysis, spectroscopy and thermal stability studies.

18 December 2015 in Molecules
Verified
Journal Article
Open access
PDF file
Ionut LedetiIonut Ledeti
Ionut Ledeti
SAStefana Avram
Stefana Avram
BNBercean V Vasile Nicolae
Bercean V Vasile Nicolae
GVGabriela Vlase
Gabriela Vlase
Vlase TitusVlase Titus
Vlase Titus
CRISTINA ADRIANA DEHELEANCRISTINA ADRIANA DEHELEAN
CRISTINA ADRIANA DEHELEAN
Betulonic acid belongs to the pentacyclic triterpenic derivative class and can be obtained through the selective oxidation of betulin. In this study we set obtaining several functionalized derivatives of this compound by its condensation with several amino compounds such as aminoguanidine, hydroxylamine, n-butylamine and thiosemicarbazide as our goal. The functionalization of the parent compound led to several molecules with antiproliferative potential, the most promising being 3–2-carbamothioylhydrazonolup-20(29)-en-28-oic acid.

19 April 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Lenuţa-Maria ŞutaLenuţa-Maria Şuta
Lenuţa-Maria Şuta
Amalia Ioana RidichieAmalia Ioana Ridichie
Amalia Ioana Ridichie
Adriana LedetiAdriana Ledeti
Adriana Ledeti
CTClaudia Temereancă
Claudia Temereancă
Ionut LedetiIonut Ledeti
Ionut Ledeti
LSLavinia Stelea
Lavinia Stelea
Itraconazole is an antifungal agent included in the triazole pharmacological classification that belongs to the BCS class II, characterized by a low solubility in an aqueous medium (of 1 ng/mL, at neutral pH), which is frequently translated in a low oral bioavailability but with a high permeability. In this sense, it is necessary to find solutions to increase/improve the solubility of itraconazole in the aqueous environment. The main purpose of this study is the preparation and analysis of five different guest–host inclusion complexes containing intraconazole. Initially, a blind docking process was carried out to determine the interactions between itraconazole and the selected cyclodextrins. The second step of the study was to find out if the active pharmaceutical ingredient was entrapped in the cavity of the cyclodextrin, by using spectroscopic and thermal techniques. Also, the antifungal activity of the inclusion complexes was studied to examine if the entrapment of itraconazole influences the therapeutic effect. The results showed that the active substance was entrapped in the cavity of the cyclodextrins, with a molar ratio of 1:3 (itraconazole–cyclodextrin), and that the therapeutic effect was not influenced by the entrapment.

6 July 2020 in Journal of Thermal Analysis and Calorimetry
Verified
Journal Article
Closed access
PDF file
Denisa IvanDenisa Ivan
Denisa Ivan
Ionut LedetiIonut Ledeti
Ionut Ledeti
Lenuţa-Maria ŞutaLenuţa-Maria Şuta
Lenuţa-Maria Şuta
GVGabriela Vlase
Gabriela Vlase
Adriana LedetiAdriana Ledeti
Adriana Ledeti
CRISTINA ADRIANA DEHELEANCRISTINA ADRIANA DEHELEAN
CRISTINA ADRIANA DEHELEAN

17 January 2024
Verified
Journal Article
Open access
Amalia Ioana RidichieAmalia Ioana Ridichie
Amalia Ioana Ridichie
Adriana LedetiAdriana Ledeti
Adriana Ledeti
DIDenisa Ivan
Denisa Ivan
CTCarmen Tomoroga
Carmen Tomoroga
Laura SbârceaLaura Sbârcea
Laura Sbârcea
Ionut LedetiIonut Ledeti
Ionut Ledeti
Mupirocin is a topical antibiotic widely used to treat various skin infections caused by Gram-positive and Gram-negative bacteria, being the first-line treatment in the case of an infection with methicillin-resistant Staphylococcus aureus (MRSA). Due to the unique mechanism of action, it does not possess any cross-resistance with other antibiotics, leading to its global use in different hospital departments. The main disadvantage of mupirocin is represented by its pharmacokinetic properties, leading to the main purpose of this study, namely, to fully characterize the physicochemical properties of the active pharmaceutical ingredient. Currently, it is used in different combinations with other active substances, for example metronidazole, to decrease the risk of developing resistance to mupirocin and to improve the therapeutic response. This leads to the second purpose of this study, i.e., to characterize the physico-chemical profile of metronidazole and to find out if there are any chemical interactions between the two compounds, and to establish if there is a possibility of using them in the same pharmaceutical formulation, thus increasing the compliance of the patient to the treatment.

19 August 2018 in Journal of Thermal Analysis and Calorimetry
Verified
Journal Article
Closed access
PDF file
Ionut LedetiIonut Ledeti
Ionut Ledeti
APAgneta Maria Pusztai
Agneta Maria Pusztai
Maria Cezara MuresanMaria Cezara Muresan
Maria Cezara Muresan
Denisa IvanDenisa Ivan
Denisa Ivan
GVGabriela Vlase
Gabriela Vlase
MMMarius Murariu
Marius Murariu